Sildenafil Tablet
Product Images NDC 68788-7974

7 FDA label images from Preferred Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68788-7974). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Sildenafil Structure)

Structure (Sildenafil Structure)
Chemical structure of Sildenafil, showing the detailed molecular arrangement of atoms including nitrogen, oxygen, and sulfur atoms characteristic to the compound.*
FDA Label Image

Figure1 (Sildenafil Fig1)

Figure1 (Sildenafil Fig1)
A forest plot chart showing drug interaction recommendations for Sildenafil 20 mg tablets by Preferred Pharmaceuticals Inc. The graph depicts changes in AUC and Cmax relative to Sildenafil alone from Day 1 to Day 7 with various interacting drugs, including Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, oral contraceptives, Ritonavir, and Saquinavir. Recommendations range from no dose adjustment to coadministration not recommended.*
FDA Label Image

Figure2 (Sildenafil Fig2)

Figure2 (Sildenafil Fig2)
A forest plot chart presenting the fold change and 95% confidence intervals of the area under the curve (AUC) and maximum concentration (Cmax) of Sildenafil when co-administered with various interacting drugs. The chart includes recommendations on dose adjustment or coadministration based on the magnitude of interaction for drugs such as Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinylestradiol, Levorogestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide.*
FDA Label Image

Figure3 (Sildenafil Fig3)

Figure3 (Sildenafil Fig3)
A line chart depicting change from baseline in meters over weeks of study (4, 8, and 12) for Sildenafil at doses of 20 mg, 40 mg, and 80 mg taken three times daily (TID), compared with placebo. The Y-axis measures change from baseline in meters, with error bars indicating variability. The chart shows increasing improvement over time for Sildenafil doses compared to placebo.*
FDA Label Image

Figure4 (Sildenafil Fig4)

Figure4 (Sildenafil Fig4)
A forest plot chart showing placebo-corrected change in 6-minute walk distance (meters) for Sildenafil 20 mg taken three times daily (TID). The chart compares subgroups by baseline walk distance, etiology, pulmonary hypertension class, gender, age, mean pulmonary arterial pressure (PAP), and pulmonary vascular resistance index (PVRI). The horizontal axis quantifies the change in walk distance in meters, with data points and 95% confidence intervals displayed for each subgroup.*
FDA Label Image

Figure5 (Sildenafil Fig5)

Figure5 (Sildenafil Fig5)
A line graph comparing the percentage of subjects without a clinically worsening event over time from randomization between Sildenafil and Placebo groups. The x-axis represents days from randomization (0 to 112), and the y-axis shows the percentage without worsening (0 to 100%). Sildenafil shows a higher percentage maintained over time compared to Placebo.*
FDA Label Image

Sildenafil Tablets 20mg (Sildenafil 20mg)

Sildenafil Tablets 20mg (Sildenafil 20mg)
Sildenafil Tablets 20 mg tablet label, generic for Revatio, with active ingredient Sildenafil Citrate equivalent to 20 mg Sildenafil. The label includes directions in English and Spanish, storage instructions, manufacturer Ajanta Pharma USA Inc., and a barcode. Labeler is Preferred Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.